Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

por Samuel P Heilbroner, Eric P Xanthopoulos, Donna Buono, Daniel Carrier, Ben Y Durkee, Michael Corradetti, Tony J C Wang, Alfred I Neugut, Dawn L Hershman, Simon K Cheng
Publicado 2021